These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 9635719)

  • 1. The effect of activation of wild-type p53 function on fluoropyrimidine-mediated radiosensitization.
    Naida JD; Davis MA; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):675-80. PubMed ID: 9635719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorodeoxyuridine-mediated cytotoxicity and radiosensitization require S phase progression.
    Lawrence TS; Davis MA; Tang HY; Maybaum J
    Int J Radiat Biol; 1996 Sep; 70(3):273-80. PubMed ID: 8800198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-fluoro-2'-deoxyuridine-induced cdc25A accumulation correlates with premature mitotic entry and clonogenic death in human colon cancer cells.
    Parsels LA; Parsels JD; Tai DC; Coughlin DJ; Maybaum J
    Cancer Res; 2004 Sep; 64(18):6588-94. PubMed ID: 15374972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lack of effect of TP53 status on fluorodeoxyuridine-mediated radiosensitization.
    Lawrence TS; Burke R; Davis MA
    Radiat Res; 2000 Aug; 154(2):140-4. PubMed ID: 10931684
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of cell cycle redistribution in radiosensitization: implications regarding the mechanism of fluorodeoxyuridine radiosensitization.
    McGinn CJ; Miller EM; Lindstrom MJ; Kunugi KA; Johnston PG; Kinsella TJ
    Int J Radiat Oncol Biol Phys; 1994 Nov; 30(4):851-9. PubMed ID: 7960987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dependence of fluorodeoxyuridine-mediated radiosensitization on S phase progression.
    Davis MA; Tang HY; Maybaum J; Lawrence TS
    Int J Radiat Biol; 1995 May; 67(5):509-17. PubMed ID: 7775826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HPV16-E7 expression causes fluorodeoxyuridine-mediated radiosensitization in SW620 human colon cancer cells.
    Axelson MD; Davis MA; Ethier SP; Lawrence TS
    Neoplasia; 1999 Jun; 1(2):177-82. PubMed ID: 10933053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of the hMLH1 DNA mismatch repair protein in fluoropyrimidine-mediated cell death and cell cycle responses.
    Meyers M; Wagner MW; Hwang HS; Kinsella TJ; Boothman DA
    Cancer Res; 2001 Jul; 61(13):5193-201. PubMed ID: 11431359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Short hairpin RNA suppression of thymidylate synthase produces DNA mismatches and results in excellent radiosensitization.
    Flanagan SA; Cooper KS; Mannava S; Nikiforov MA; Shewach DS
    Int J Radiat Oncol Biol Phys; 2012 Dec; 84(5):e613-20. PubMed ID: 22867891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluorodeoxyuridine-induced radiosensitization and inhibition of DNA double strand break repair in human colon cancer cells.
    Bruso CE; Shewach DS; Lawrence TS
    Int J Radiat Oncol Biol Phys; 1990 Dec; 19(6):1411-7. PubMed ID: 2148170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dependence of fluorodeoxyuridine-induced cytotoxicity and megabase DNA fragment formation on S phase progression in HT29 cells.
    Tang HY; Weber KL; Lawrence TS; Merchant AK; Maybaum J
    Cancer Chemother Pharmacol; 1996; 37(5):486-90. PubMed ID: 8599873
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lack of dependence of 5-fluorodeoxyuridine-mediated radiosensitization on cytotoxicity.
    Lawrence TS; Davis MA; Chang EY; Canman CE; Maybaum J; Radany EH
    Radiat Res; 1995 Sep; 143(3):281-5. PubMed ID: 7652165
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoropyrimidine-mediated radiosensitization depends on cyclin E-dependent kinase activation.
    Lawrence TS; Davis MA; Loney TL
    Cancer Res; 1996 Jul; 56(14):3203-6. PubMed ID: 8764107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of fluorodeoxyuridine-induced cytotoxicity and DNA damage in HT29 colon carcinoma cells by conditional expression of wild-type p53 phenotype.
    Parsels LA; Zellars RC; Loney TL; Parsels JD; Clarke MF; Merchant AK; Lawrence TS; Maybaum J
    Mol Pharmacol; 1997 Oct; 52(4):600-5. PubMed ID: 9380022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of leucovorin and dipyridamole on fluoropyrimidine-induced radiosensitization.
    Lawrence TS; Heimburger DK; Shewach DS
    Int J Radiat Oncol Biol Phys; 1991 Feb; 20(2):377-81. PubMed ID: 1991704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MLH1 deficiency enhances radiosensitization with 5-fluorodeoxyuridine by increasing DNA mismatches.
    Flanagan SA; Krokosky CM; Mannava S; Nikiforov MA; Shewach DS
    Mol Pharmacol; 2008 Sep; 74(3):863-71. PubMed ID: 18535288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluorodeoxyuridine-mediated modulation of iododeoxyuridine incorporation and radiosensitization in human colon cancer cells in vitro and in vivo.
    Lawrence TS; Davis MA; McKeever PE; Maybaum J; Stetson PL; Normolle DP; Ensminger WD
    Cancer Res; 1991 Aug; 51(15):3900-5. PubMed ID: 1830239
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.
    Ren Q; Kao V; Grem JL
    Clin Cancer Res; 1998 Nov; 4(11):2811-8. PubMed ID: 9829747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell-cycle arrest and p53-independent induction of apoptosis in vitro by the new anticancer drugs 5-FdUrd-P-FdCydOct and dCydPam-P-FdUrd in DU-145 human prostate cancer cells.
    Cattaneo-Pangrazzi RM; Schott H; Wunderli-Allenspach H; Rothen-Rutishauser B; Guenthert M; Schwendener RA
    J Cancer Res Clin Oncol; 2000 May; 126(5):247-56. PubMed ID: 10815759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
    Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
    J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.